Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA: 603882)

Guangzhou Kingmed Diagnostics Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	7,438	7,726	14,529	11,304	7,870	4,965
Other Revenue	813.43	813.43	946.76	639.52	373.96	304.43
Revenue	8,251	8,540	15,476	11,943	8,244	5,269
Revenue Growth (YoY)	-25.35%	-44.82%	29.58%	44.88%	56.45%	16.44%
Cost of Revenue	5,319	5,425	8,802	6,295	4,395	3,189
Gross Profit	2,932	3,115	6,674	5,648	3,849	2,080
Selling, General & Admin	1,720	1,730	2,506	2,323	1,613	1,288
Research & Development	409.7	467.14	632.62	517.93	397.17	324.02
Other Operating Expenses	183.48	14.91	14.75	11.71	6.93	6.31
Operating Expenses	2,781	2,700	3,409	2,924	2,064	1,642
Operating Income	151.64	414.93	3,266	2,724	1,785	437.85
Interest Expense	-18.84	-20.39	-23.65	-27.55	-29.26	-37.64
Interest & Investment Income	283.57	288.36	30.4	21.53	13.76	51.74
Currency Exchange Gain (Loss)	0.04	-0.6	9.14	-1.46	-0.2	-0
Other Non Operating Income (Expenses)	8.53	-2.95	-3.91	-2.54	-2.03	-1.3
EBT Excluding Unusual Items	424.93	679.35	3,278	2,714	1,767	450.65
Gain (Loss) on Sale of Investments	5.31	-	-10.8	-7.29	-18.66	-1.76
Gain (Loss) on Sale of Assets	-4.09	-7.57	2.97	-10.11	1.43	-0.16
Other Unusual Items	85.09	68.51	50.64	50.87	60.42	47
Pretax Income	511.24	740.29	3,321	2,748	1,810	495.72
Income Tax Expense	73.3	103.38	475.72	384.05	237.04	80.46
Earnings From Continuing Operations	437.93	636.91	2,845	2,364	1,573	415.26
Minority Interest in Earnings	10.25	6.47	-90.22	-143.87	-63.73	-12.93
Net Income	448.19	643.38	2,755	2,220	1,510	402.33
Net Income to Common	448.19	643.38	2,755	2,220	1,510	402.33
Net Income Growth	-67.91%	-76.64%	24.11%	47.03%	275.24%	72.44%
Shares Outstanding (Basic)	469	466	466	462	459	457
Shares Outstanding (Diluted)	469	466	467	466	462	457
Shares Change (YoY)	0.38%	-0.15%	0.13%	1.00%	0.98%	-0.07%
EPS (Basic)	0.96	1.38	5.91	4.80	3.29	0.88
EPS (Diluted)	0.96	1.38	5.90	4.76	3.27	0.88
EPS Growth	-68.03%	-76.61%	23.95%	45.57%	271.59%	72.55%
Free Cash Flow	279.37	516.07	1,107	1,136	972.45	386.47
Free Cash Flow Per Share	0.60	1.11	2.37	2.44	2.11	0.85
Dividend Per Share	0.880	0.880	1.780	1.280	0.329	0.136
Dividend Growth	-50.56%	-50.56%	39.06%	289.06%	141.91%	25.93%
Gross Margin	35.54%	36.48%	43.13%	47.29%	46.69%	39.48%
Operating Margin	1.84%	4.86%	21.10%	22.81%	21.65%	8.31%
Profit Margin	5.43%	7.53%	17.80%	18.58%	18.31%	7.64%
Free Cash Flow Margin	3.39%	6.04%	7.15%	9.51%	11.80%	7.33%
EBITDA	595.81	859.27	3,679	3,056	2,066	694.4
EBITDA Margin	7.22%	10.06%	23.77%	25.58%	25.06%	13.18%
D&A For EBITDA	444.17	444.34	412.85	331.56	280.85	256.55
EBIT	151.64	414.93	3,266	2,724	1,785	437.85
EBIT Margin	1.84%	4.86%	21.10%	22.81%	21.65%	8.31%
Effective Tax Rate	14.34%	13.96%	14.33%	13.98%	13.09%	16.23%
Revenue as Reported	8,112	8,540	15,476	11,943	8,244	5,269
Advertising Expenses	-	2.16	3.29	3.16	2.71	1.75

Source: S&P Capital IQ. Standard template. Financial Sources.